News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Synteract Becomes First Medidata Service Partner Accredited in Rave Safety Gateway


12/7/2011 7:05:01 AM

BERLIN--(BUSINESS WIRE)--BIOTRONIK today announced the publication of the COMPAS clinical trial results in the European Heart Journal1. COMPAS is the first large-scale, prospective, multi-center, randomized clinical trial to demonstrate the safety and efficacy of remote monitoring with BIOTRONIK Home Monitoring® in pacemaker patients. The results further confirm BIOTRONIK Home Monitoring® as the remote monitoring system with the strongest and most robust clinical evidence in the industry.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES